PF-Atlas › Clinical Trials › NCT07230288

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

ABBV-142 · Phase 2

Registry ID

NCT07230288

Phase

Phase 2

Status

Recruiting

Drug / intervention

ABBV-142

Sponsor

AbbVie

Start

2026-01-23

About this trial

ABBV-142 is evaluated in NCT07230288, a Phase 2 idiopathic pulmonary fibrosis study sponsored by AbbVie. Current status: Recruiting.

View NCT07230288 on ClinicalTrials.gov →

Explore related

All ABBV-142 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT07230288 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.